Chong Kun Dang Pharmaceutical Analysis
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
2039.37
|
2336.19
|
296.82
|
14.55%
|
|
2022-06-30
|
1901.80
|
1977.00
|
75.20
|
3.95%
|
|
2022-03-31
|
1627.60
|
1484.00
|
-143.60
|
-8.82%
|
|
2021-12-31
|
1169.67
|
144.00
|
-1025.67
|
-87.69%
|
|
2021-09-30
|
2035.57
|
180.95
|
-1854.62
|
-91.11%
|
|
2021-06-30
|
2235.07
|
2119.00
|
-116.07
|
-5.19%
|
|
2021-03-31
|
1856.66
|
1327.41
|
-529.25
|
-28.51%
|
|
2020-12-31
|
1005.69
|
1033.18
|
27.49
|
2.73%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
5797.19
|
|
2021-12-31
|
3771.36
|
|
2020-12-31
|
7457.64
|
|
2019-12-31
|
4363.68
|
|
2018-12-31
|
3953.68
|
|
2017-12-31
|
4589.17
|
|
2016-12-31
|
3249.19
|
|
2015-12-31
|
-537.44
|
|
2014-12-31
|
2789.55
|